About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Anti-Stroke Drug Reduces Mortality and Disability Risk of Intraventricular Hemorrhage

by Reshma Anand on February 19, 2016 at 4:06 PM
Font : A-A+

Anti-Stroke Drug Reduces Mortality and Disability Risk of Intraventricular Hemorrhage

Breakthrough Phase III trial results of a clot-busting drug have revealed its potential to reduce intraventricular hemorrhage and the chances of developing disability associated with the condition.

An intraventricular hemorrhage is a severe form of stroke leading to clotting of blood in the brain's ventricles. The condition has no treatment and the affected individuals have very less survival chances. This type of stroke also leads to disability.

Advertisement


Researchers from the Johns Hopkins University and the University of Chicago conducted the CLEAR III clinical trial among 500 patients. They used a clot-busting drug called alteplase, also known as tPA to check its potential in reducing blood clots. One group of patients were administered tPA through a brain catheter while another group was given saline through the catheter.

The patients received the tPA for three days and a catheter continually drained blood until the ventricle got cleared. They found that tPA reduced the death rates by 10% and almost doubled the survival chances of patients who had most of the blood removed.
Advertisement

They also found that the more blood was cleared, the odds of developing post-stroke disability reduced among the patients. The results nearly doubled in patients who had 90 percent of their clots removed.

"Hemorrhage in the brain used to be an essentially untreatable condition, but we now have hope with a therapy that may be effective at saving lives," said Dr.Issam Awad, John Harper Seeley Professor of Surgery at the University of Chicago Medicine, who was co-chair and surgical director for the CLEAR III clinical trial.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 

Most Popular on Medindia

Indian Medical Journals Sinopril (2mg) (Lacidipine) Calculate Ideal Weight for Infants The Essence of Yoga A-Z Drug Brands in India Loram (2 mg) (Lorazepam) Noscaphene (Noscapine) Find a Doctor Iron Intake Calculator Diaphragmatic Hernia
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Anti-Stroke Drug Reduces Mortality and Disability Risk of Intraventricular Hemorrhage Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests